Filing Details
- Accession Number:
- 0001209191-18-033936
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-29 17:54:54
- Reporting Period:
- 2018-05-24
- Accepted Time:
- 2018-05-29 17:54:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1337553 | Aerie Pharmaceuticals Inc | AERI | Biological Products, (No Disgnostic Substances) (2836) | 203109565 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590001 | C. Casey Kopczynski | C/O Aerie Pharmaceuticals, Inc. 4301 Emperor Blvd., Suite 400 Durham NC 27703 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-24 | 3,000 | $5.00 | 194,517 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-24 | 292 | $50.41 | 194,225 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-05-29 | 2,708 | $50.15 | 191,517 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Disposition | 2018-05-24 | 3,000 | $0.00 | 3,000 | $5.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-10-30 | 2020-08-27 | No | 4 | M | Direct |
Billionaire Hedge Funds
